Table 2.
Reference | Amino acid change | Inheritance pattern | Epilepsyage of onset | Epilepsy type | DD | MRI |
---|---|---|---|---|---|---|
Holland et al, 2008 | p.Lys354Gln | Paternal | 2 y | Focal | No | Normal |
Vanoye et al, 2014 | p.Arg357Gln | Unknown | 4 y | Focal | Yes | Normal |
Vanoye et al, 2014 | p.Asp815Asn | Unknown | 22 mo | Focal | Mild | Normal |
Vanoye et al, 2014 | p.Glu1160Lys | Unknown | Neonate | Focal | No | Normal |
Vanoye et al, 2014 | p.Met1372Val | Unknown | 16 mo | FS; Focal | No | Normal |
Wang et al, 2017 | p.Arg621Cys | Maternal | Unkown | FS; BECTS | No | Normal |
Lamar et al, 2017 | p.Leu247Pro | de novo | 18 mo | Focal | Yes | Normal |
Trujillano et al, 2017 | p.Pro1333Leu | de novo | 1-3 d | Unspecified | Severe | Normal |
Note that all variants are presented in relation to Nav1.3 isoform 1 (Reference Sequence NP_008853.3) FS, febrile seizures; BECTS, centrotemporal spikes on EEG.